Top pharma firms get notices for overcharging

The National Pharmaceutical Pricing Authority (NPPA) has issued preliminary notices to several pharmaceutical companies for 613 cases of over-charging. 

The office order, issued on Friday, said companies which had been found overcharging included Sun Pharmaceutical, Dr Reddy’s Laboratories, GlaxoSmithKline, Abbott, Alembic Pharmaceuticals, Intas Pharmaceutical, Sanofi, Torrent Pharmaceuticals, Zydus Cadila, Wockhardt, Cipla and Lupin, among others.

The pharma pricing authority’s previous list in February said that there were 634 cases of overcharging. 

The authority maintained that it was witnessing a large number of non-compliance cases every month. 

The latest office order stated that since violations were too many, the NPPA would now issue collective show-cause